drug · antibody
teplizumab
pre_registrationupdated 3mo agoby $SNY Sanofi🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 6Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for type 1 diabetes mellitus and 3 investigational indications.
targets
T-cell surface glycoprotein CD3 epsilon chain
all catalysts(1)
Trials studying teplizumab
- phase3A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- —Long-Term Outcomes of Teplizumab in Routine Clinical Care
- —Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
- —Registry for Stage 2 Type 1 Diabetes
- phase2Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes
- phase4Teplizumab in Pediatric Stage 2 Type 1 Diabetes
- —Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension)
- —A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States
News(6)
- Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independenceAfter the trailblazing approval of Sanofi’s Tzield for stage 3 type 1 diabetes, several companies, including SAB Biotherapeutics and Eledon Pharmaceuticals, are vying for a spot in the landscape wi…biospace · 26d ago
- FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 DiabetesOn June 12, 2026, the U.S. Food and Drug Administration granted accelerated approval to Tzield (teplizumab) for a new indication, to delay the decline of insulin production in pediatric patients ag…fda_press · 2mo ago
- STAT+: Lilly’s Ajax acquisition may have been worth itA syphilis drug shortage, Sanofi's diabetes drug approval, and more biotech news from The Readoutstat · 2mo ago
- STAT+: FDA approves Sanofi diabetes drug for children with stage 3 diabetesThe FDA has approved a drug that was previously caught in a dispute between career staff and the political appointee head of the CDER.stat · 2mo ago
- STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and moreSanofi asked the FDA to pull teplizumab out of a speedy review voucher program after a political appointee disagreed with staff over its approvalstat · 3mo ago
- STAT+: Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered with reviewSanofi has asked the FDA to pull its type 1 diabetes drug out of Commissioner Marty Makary’s new speedy drug review program.stat · 3mo ago
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that